Propranolol vs Nebivolol

Propranolol wins for acute management of adrenaline-driven tremor, performance anxiety, and stimulant-induced tachycardia. Its non-selective β-blockade rapidly suppresses physical symptoms during peak week, photoshoots, or as a rescue for clenbuterol side effects.

Nebivolol wins for daily blood-pressure management, especially on-cycle or during heavy PED use. It delivers clean β₁ selectivity with unique nitric oxide–mediated vasodilation, preserving pumps, erectile response, and cardio endurance—making it optimal for long-term cardiovascular support without the downsides of older beta blockers.

Pick Propranolol if:

• The research protocol calls for acute suppression of tremor or anxiety during posing, competition, or live events.
• A rapid, short-term rescue is needed for stimulant-driven tachycardia or palpitations (clenbuterol, ephedrine, or high-dose caffeine protocols).
• The event window is limited to a single day or several hours, not a chronic condition.
• Physical performance impairment (VO₂max, stamina) is acceptable for the session.
• No underlying contraindications like asthma, advanced heart block, or stimulant use (e.g., cocaine) are present.

Pick Nebivolol if:

• The protocol involves daily management of PED-induced elevated blood pressure or heart rate.
• Preservation of training output, pumps, and erectile function are priorities (especially when running high-dose androgens or orals).
• Long-term cardiovascular protection is needed as part of a stacked approach (alongside telmisartan or tadalafil).
• The research goal is to avoid typical beta-blocker lethargy and metabolic downsides.
• The subject requires ongoing support, not just acute event management.